Anti-CD3 antibodies and methods of use thereof

TW202635721APending Publication Date: 2026-09-01THIRD ARC BIO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114139668
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-21
Filing Date
2025-10-15
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074371_001
    Figure TWG2TA001074371_001
  • Figure TWG2TA001074371_002
    Figure TWG2TA001074371_002
  • Figure TWG2TA001074371_003
    Figure TWG2TA001074371_003
Patent Text Reader

Abstract

Antibodies and antigen-binding fragments thereof that specifically bind CLDN6 or CD3, and bispecific antibodies and antigen-binding domains that specifically bind CLDN6 and CD3 are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
Need to check novelty before this filing date? Find Prior Art